Items Tagged ‘Gastrointestinal Stromal Tumors’

February 11th, 2016

Vistogard® Approved for Life-Threatening Toxicities of Certain Chemotherapy Agents

By

The United States Food and Drug Administration (FDA) approved Vistogard (uridine triacetate) for the treatment of life-threatening toxicities caused by the chemotherapy drugs fluorouracil or capecitabine. The approved indication is for the “emergency treatment of adults and children who receive an overdose of the cancer treatment fluorouracil or Xeloda (capecitabine), or who develop certain severe […]

View full entry

Tags: Anal Cancer, Breast Cancer, capecitabine, Colon Cancer, fda, fluorouracil, Gastric Cancer, Gastrointestinal Stromal Tumors, life-threatening, Liver Cancer, News, Pancreatic Cancer


August 31st, 2011

Clinical Trial Participation Is Inadequate

By

A large proportion of cancer patients do not enroll in clinical trials, and those who do participate may not adequately represent age groups, cancer stages, cancer types, and racial and ethnic groups. These findings were recently reported in the Annals of Surgery. Clinical trials are the process through which medications ultimately become approved by the […]

View full entry

Tags: All Cancer Types, Anal Cancer, Bladder Cancer, Bone Cancer, Brain Cancer, Breast Cancer, Cervical Cancer, Colon Cancer, Esophageal Cancer, Gastric Cancer, Gastrointestinal Stromal Tumors, Head and Neck Cancer


July 15th, 2011

Stay on Top of Your Family History of Cancer

By

People who are at high risk of cancer as a result of their family history may be advised to undergo earlier or more intensive cancer screening. Because family history of cancer can change over time, it’s important to update this information periodically with your healthcare provider. This was the conclusion of a study published in […]

View full entry

Tags: All Cancer Types, Anal Cancer, Bladder Cancer, Bone Cancer, Brain Cancer, Breast Cancer, Cervical Cancer, Colon Cancer, Esophageal Cancer, Gastric Cancer, Gastrointestinal Stromal Tumors, General Bone Cancer


July 11th, 2011

Survivors of Childhood Cancer Face Risk of More Cancer

By

Children who survive cancer have an increased risk of developing cancer later in life. These findings were recently reported in the Journal of Clinical Oncology. The good news about childhood cancer is that increasingly more children are surviving. These improved outcomes, however, present new concerns, as long-term health of these individuals may be compromised due […]

View full entry

Tags: All Cancer Types, Anal Cancer, Bladder Cancer, Bone Cancer, Brain Cancer, Breast Cancer, Cervical Cancer, Colon Cancer, Esophageal Cancer, Gastric Cancer, Gastrointestinal Stromal Tumors, Head and Neck Cancer


June 21st, 2011

New Substances Added to List of Cancer-Causing Agents

By

In the most recent version of the National Toxicology Program’s Report on Carcinogens, two new substances have been classified as “known human carcinogens” and six others have been classified as “reasonably anticipated to be human carcinogens.” The National Toxicology Program is headquartered at the National Institute of Environmental Health Sciences, part of the National Institutes […]

View full entry

Tags: All Cancer Types, Anal Cancer, Bladder Cancer, Bone Cancer, Brain Cancer, Breast Cancer, Cervical Cancer, Colon Cancer, Esophageal Cancer, Gastric Cancer, Gastrointestinal Stromal Tumors, Gene Therapy


June 21st, 2011

Medical Costs Higher Among Survivors

By

Cancer survivors tend to pay substantially more in annual medical costs compared with people who have never had cancer. These findings were recently reported in Cancer. A significant number of adults in the United States are cancer survivors—approximately 12 million—and, as the population ages, this number is likely to grow. As increasingly more people are […]

View full entry

Tags: All Cancer Types, Anal Cancer, Bladder Cancer, Bone Cancer, Brain Cancer, Breast Cancer, Cervical Cancer, Colon Cancer, Esophageal Cancer, Gastric Cancer, Gastrointestinal Stromal Tumors, Head and Neck Cancer


June 9th, 2011

Three Years of Treatment with Gleevec Improves Survival in Gastrointestinal Stromal Tumors (GIST)

By

Treatment with Gleevec® (imatinib) for 3 years following surgery significantly improves survival compared with the standard one-year therapy for patients with gastrointestinal stromal tumors (GIST). GIST is a type of soft tissue sarcoma that develops in the stomach, small intestine, or other parts of the gastrointestinal tract. Treatment of early GIST often involves surgery followed […]

View full entry

Tags: Gastrointestinal Stromal Tumors, News


April 11th, 2011

Fewer Lung Cancer Deaths Among Women

By

The lung cancer death rate among women appears to be declining for the first time in 40 years, according to an annual report published by multiple institutions. Findings from the report were recently released in the Journal of the National Cancer Institute. A report on the status of cancer is published each year by the […]

View full entry

Tags: Anal Cancer, Bladder Cancer, Bone Cancer, Brain Cancer, Breast Cancer, Cervical Cancer, Colon Cancer, Esophageal Cancer, Gastric Cancer, Gastrointestinal Stromal Tumors, Head and Neck Cancer, HIV Related Cancers


February 1st, 2011

Nexavar Shows Promise against Drug-Resistant GIST

By

Among patients with gastrointestinal stromal tumors (GIST) that were resistant to both Gleevec® (imatinib) and Sutent® (sunitinib), treatment with Nexavar® (sorafenib) resulted in tumor shrinkage or stable disease in 68% of patients. The results of this Phase II clinical trial were presented at the 2011 Gastrointestinal Cancers Symposium. GIST is a type of soft tissue […]

View full entry

Tags: Gastrointestinal Stromal Tumors, News